codeine sulfate

Also found in: Dictionary, Thesaurus, Encyclopedia.

codeine sulfate

Pharmacologic class: Opioid agonist

Therapeutic class: Opioid analgesic, antitussive

Controlled substance schedule II Pregnancy risk category C


Binds to opioid receptors in CNS, altering perception of painful stimuli. Causes generalized CNS depression, decreases cough reflex, and reduces GI motility.


Tablets: 15 mg, 30 mg, 60 mg

Indications and dosages

Mild to moderately severe pain

Adults: 15 to 60 mg P.O. q 4 hours as needed. Doses above 60 mg may fail to give commensurate pain relief, and may be associated with an increased incidence of undesirable adverse effects.

Dosage adjustment

• Renal or hepatic impairment

• Elderly or debilitated patients


• Hypersensitivity to drug, its components, or other opioids

• Respiratory depression, severe bronchial asthma, hypercarbia

• Paralytic ileus or suspected paralytic ileus


Use cautiously in:

• severe renal, hepatic, or pulmonary disease

• adrenal insufficiency, circulatory shock, hypotension, pancreatic or biliary tract disease, urethral stricture, seizures, head trauma, hypothyroidism, increased intracranial pressure, prostatic hypertrophy, undiagnosed abdominal pain, alcoholism

• concomitant use of alcohol, other opioids, illicit drugs

• elderly or debilitated patients

• pregnant or breastfeeding patients

• labor and delivery patients

• children younger than age 18 (safety and efficacy not established).


• If GI upset occurs, give with food.

• Titrate dosage for appropriate analgesic effect.

If overdose occurs, give naloxone I.V. as prescribed. Repeat administration as needed (up to manufacturer's recommended maximum dosage) to reverse toxic effects.

Adverse reactions

CNS: confusion, sedation, malaise, agitation, euphoria, floating feeling, headache, hallucinations, unusual dreams, apathy, mood changes

CV: hypotension, bradycardia, peripheral vasodilation, reduced peripheral resistance

EENT: blurred or double vision, miosis, reddened sclera

GI: nausea, vomiting, constipation, decreased gastric motility

GU: urinary retention, urinary tract spasms, urinary urgency

Respiratory: suppressed cough reflex, respiratory depression

Skin: flushing, sweating

Other: physical or psychological drug dependence, drug tolerance


Drug-drug. Antidepressants, antihistamines, sedative-hypnotics: additive CNS depression

Nalbuphine, pentazocine: decreased analgesic effect

Opioid partial agonists (buprenorphine, butorphanol, nalbuphine, pentazocine): precipitation of opioid withdrawal in physically dependent patients

Drug-herbs. Chamomile, hops, kava, skullcap, valerian: increased CNS depression

Drug-behaviors. Alcohol use: increased CNS depression

Patient monitoring

• Monitor vital signs and CNS status.

• Assess pain level and efficacy of pain relief.

• Evaluate patient for adverse reactions.

Stay alert for overdose signs and symptoms, such as CNS and respiratory depression, GI cramping, and constipation.

• Assess other drugs in patient's drug regimen for those that could cause additive or adverse interactions.

• Monitor patient for signs and symptoms of drug dependence or tolerance.

Patient teaching

• Teach patient to minimize adverse GI effects by taking doses with food or milk.

Tell patient to notify prescriber promptly if he experiences shortness of breath or difficulty breathing or if nausea, vomiting, or constipation become pronounced.

• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration, alertness, vision, coordination, and physical dexterity.

• Instruct patient to move slowly when sitting up or standing, to avoid dizziness or light-headedness from sudden blood pressure decrease.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, herbs, and behaviors mentioned above.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved

co·deine sul·fate

a water-soluble salt of codeine, often used in solid pharmaceutical dosage forms. Also used in preparations in which the drug suppresses the cough reflex.
Farlex Partner Medical Dictionary © Farlex 2012

codeine sulfate

The sulfate of the alkaloid codeine. It has the same uses as codeine.
See also: codeine
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
The mean norcodeine [C.sub.max] was 17.1 [+ or -] 3.1 [micro]g/L (range, 3.9-58 [micro]g/L) after the 60 mg/70 kg dose and 46.7 [+ or -] 17.0 [micro]g/L (range, 10.3-191.2 [micro]g/L) after the 120 mg/70 kg dose of codeine sulfate. The mean disposition profile of norcodeine in oral fluid followed a time course similar to that in plasma (Fig.
Pharmaceutical company Lannett Company (NYSE:LCI) revealed on Monday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Codeine Sulfate Tablets USP, a schedule II controlled substance, 15 mg, 30 mg and 60 mg.